ASRT

Assertio Stock Price

0.6611
0.0093 (1.43%)
Upgrade to Real-Time
Afterhours (Closed)
0.6611
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Assertio Holdings Inc ASRT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0093 1.43% 0.6611 20:00:00
Close Price Low Price High Price Open Price Previous Close
0.6611 0.6333 0.6718 0.6504 0.6518
Bid Price Ask Price Spread News
0.6601 0.75 0.0899 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,816 504,270 $ 0.6599921 $ 332,814 504,952 0.55 - 1.695
Last Trade Time Type Quantity Stock Price Currency
19:06:50 70 $ 0.67 USD

Assertio Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 70.82M 107.12M 106.13M $ 229.51M $ - -3.09 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 1.28k 5.90%

more financials information »

Assertio News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ASRT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.750.800.63330.6866594574,381-0.0889-11.85%
1 Month0.7920.850.63330.7204072498,978-0.1309-16.53%
3 Months0.811.150.63330.8394655653,422-0.1489-18.38%
6 Months0.68611.460.610.86011771,024,497-0.025-3.64%
1 Year1.461.6950.551.041,619,650-0.7989-54.72%
3 Years7.3010.050.552.011,211,709-6.64-90.94%
5 Years7.3010.050.552.011,211,709-6.64-90.94%

Assertio Description

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.


Your Recent History
NASDAQ
ASRT
Assertio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.